Avery Biopharma Consulting


Accelerating Innovation

We bridge traditional clinical development with next-generation trial execution to bring therapeutics to market faster.

About Us

At Avery BioPharma Consulting, we specialize in conducting thorough due diligence on life sciences companies for venture funds, ensuring informed investment decisions that align with the future of drug development. With over 20 years of experience and a deep understanding of both traditional and cutting-edge clinical trials, we partner with companies transforming the biopharma landscape. From start-up biotech firms to established CROs, we bring structure to the chaos of clinical development, simplifying the complex and accelerating the pace of discovery.

We reduce inefficiencies that cost millions of dollars and delay life-saving therapeutics. Whether you’re evaluating an investment opportunity, scaling your biopharma start-up, or exploring innovative trial solutions, we bring actionable insights and proven expertise to every stage of your journey.

Our Partnerships

  • "Avery Biopharma brought unmatched expertise to our team, streamlining our clinical operations and getting our product to market faster than we thought possible."

  • "Their strategic insights and hands-on approach transformed our development process, turning chaos into a clear, actionable plan. We couldn’t have asked for better partners."

  • "Lan is a true expert in navigating the complexities of biotech. Her guidance was instrumental in aligning our regulatory strategy with our business goals."

  • "Working with Avery Biopharma was a game-changer. They not only brought innovative solutions to the table but also helped us build the right partnerships to scale our company."

  • "From day one, they were invested in our success. Avery Biopharma’s ability to simplify complex clinical processes and maintain focus on the big picture made all the difference."

Our Services

Get in Touch!

Contact us today and explore how we can support your biopharma development needs.